These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20398587)

  • 1. Transforming strategies for the prevention of chronic HBV and HCV infections.
    Ward JW; Hu DJ; Alter MJ; Kanwal F; Taylor C; Block JM; Caballero JB; Chase D; Saly M; Sandt L; Swan T
    J Fam Pract; 2010 Apr; 59(4 Suppl):S23-8. PubMed ID: 20398587
    [No Abstract]   [Full Text] [Related]  

  • 2. Transforming strategies to provide access to care.
    Jacobson IM; Wang S; Edlin BR; Smith VK; Chow EA
    J Fam Pract; 2010 Apr; 59(4 Suppl):S59-64. PubMed ID: 20398592
    [No Abstract]   [Full Text] [Related]  

  • 3. Transforming the current infrastructure for combating HBV and HCV infections.
    Kim WR; Ward JW; Cheever LW; Dan C; Dee L; Zola J
    J Fam Pract; 2010 Apr; 59(4 Suppl):S65-70. PubMed ID: 20398593
    [No Abstract]   [Full Text] [Related]  

  • 4. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for prevention, screening, and diagnosis of HBV and HCV infections.
    Peters MG; Weinbaum C; Tan L; Baine WB; Dienstag JL; Liang TJ; So S
    J Fam Pract; 2010 Apr; 59(4 Suppl):S29-35. PubMed ID: 20398588
    [No Abstract]   [Full Text] [Related]  

  • 6. [Medical care of patients with chronic hepatitis B].
    Marschall T; Prüfer-Krämer L; Krämer A
    MMW Fortschr Med; 2008 Sep; 150 Suppl 3():105-11. PubMed ID: 19025208
    [No Abstract]   [Full Text] [Related]  

  • 7. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates).
    Almasio PL; Babudieri S; Barbarini G; Brunetto M; Conte D; Dentico P; Gaeta GB; Leonardi C; Levrero M; Mazzotta F; Morrone A; Nosotti L; Prati D; Rapicetta M; Sagnelli E; Scotto G; Starnini G
    Dig Liver Dis; 2011 Aug; 43(8):589-95. PubMed ID: 21256097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of factors affecting HBV and HCV infections in premature children].
    Chlebna-Sokół D; Ligenza I; Krajewski P
    Przegl Epidemiol; 1997; 51(3):239-46. PubMed ID: 9411494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fighting against viral hepatitis B and C: which policy for prevention?].
    Jullien-Depradeux AM; Le Quellec-Nathan M; Postel-Vinay N; Coquin Y; Dab W
    Rev Prat; 2005 Mar; 55(6):585-6. PubMed ID: 15913108
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B and C in children.
    Hsu EK; Murray KF
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jun; 5(6):311-20. PubMed ID: 18414457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What risk is a health care worker infected with hepatitis B or C virus for his patients?].
    Husa P; Husová L
    Vnitr Lek; 2004 Oct; 50(10):771-6. PubMed ID: 15633933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dawn of a new era: transforming our domestic response to hepatitis B & C.
    El-Serag H; Lok AS; Thomas DL
    Gastroenterology; 2010 Apr; 138(4):1225-30, 1230.e1-3. PubMed ID: 20176024
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities.
    Perumalswami PV; Factor SH; Kapelusznik L; Friedman SL; Pan CQ; Chang C; Di Clemente F; Dieterich DT
    J Hepatol; 2013 May; 58(5):890-7. PubMed ID: 23333446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Knowledge about HBV, prevention behaviour and treatment adherence of patients with chronic hepatitis B in a large referral centre in Germany].
    Lutgehetmann M; Meyer F; Volz T; Lohse AW; Fischer C; Dandri M; Petersen J
    Z Gastroenterol; 2010 Sep; 48(9):1126-32. PubMed ID: 20839162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic viral hepatitis B and C. Epidemiology, diagnosis, etiology, prevention].
    Castera L; Dhumeaux D; Pawlotsky JM
    Rev Prat; 2001 Jun; 51(11):1247-57. PubMed ID: 11503496
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic viral hepatitis as a public health issue in the world.
    Lavanchy D
    Best Pract Res Clin Gastroenterol; 2008; 22(6):991-1008. PubMed ID: 19187863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic hepatitis B and C in HIV-infected patients].
    Opravil M; Hunziker R; Lüthy R; Grob PJ
    Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the viral hepatitis problem.
    Lok AS; Kim WR; El-Serag HB; Maddrey WC
    J Fam Pract; 2010 Apr; 59(4 Suppl):S11-6. PubMed ID: 20398585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.